Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Hematology|January 23, 2017
Body mass index is a prognostic factor in adult patients with acute myeloid leukemiaTaiki Ando, Etsuko Yamazaki, Eriko Ogusa, et al.
Leukemia & Lymphoma|June 9, 2016
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemiaEtsuko Yamazaki, Heiwa Kanamori, Megumi Itabashi, et al.
Leukemia Research|April 14, 2015
R-CHOP therapy alone for limited-stage follicular lymphomaNaoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, et al.
European Journal of Haematology|November 29, 2013
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab eraReina Watanabe, Naoto Tomita, Megumi Itabashi, et al.
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.
International Journal of Hematology|April 10, 2019
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemiaTaiki Ando, Shin Fujisawa, Haruka Teshigawara, et al.
Hematological Oncology|July 7, 2017
Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study)Hideki Nakasone, Kiriko Terasako-Saito, Teiichi Hirano, et al.
Cancer Science|January 24, 2014
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Shin Fujisawa, Maki Hagihara, et al.
British Journal of Haematology|February 26, 2013
R-CHOP therapy alone in limited stage diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Kazuho Miyashita, et al.
International Journal of Hematology|November 24, 2020
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study GroupTakeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, et al.
Pageof 8